Summary: Researchers developed a novel peptide, KS-133, to target cognitive dysfunction in schizophrenia. By using a brain-targeting peptide, KS-487, they successfully transported KS-133 across the blood-brain...
Put your thankfulness hat on. On Friday, the universe is feeling generous. Several tarot cards are in the reverse position, revealing that many of us won’t...
A federal jury in L.A. ordered the NFL to pay aggrieved sports fans a total of $4.7 billion after finding the league conspired with DirecTV and...